Partner’s problem solved by applying Glantreo’s materials science technology
Microarray technology represents a multiplexed, high-throughput biomolecular assay which is poised to meet the demand for personalised medicine. As this technology allows for rapid and robust analysis, with increased resolution and scope for customisation compared to traditional diagnostic methods, it is only a matter of time before microarrays make the transition from R&D to the clinical setting. However, as the analyte repertoire is expanding and the physical sizes of biopsy samples are decreasing, there is a pressure on microarray technology to first become more versatile and more sensitive. This will require optimization of the current microarray slide format to produce a surface with enhanced molecular compatibility and possessing a variety of binding affinities.